JP2019526631A - 皮膚真菌感染症の処置のための方法及び組成物 - Google Patents

皮膚真菌感染症の処置のための方法及び組成物 Download PDF

Info

Publication number
JP2019526631A
JP2019526631A JP2019531863A JP2019531863A JP2019526631A JP 2019526631 A JP2019526631 A JP 2019526631A JP 2019531863 A JP2019531863 A JP 2019531863A JP 2019531863 A JP2019531863 A JP 2019531863A JP 2019526631 A JP2019526631 A JP 2019526631A
Authority
JP
Japan
Prior art keywords
treatment
solution
terbinafine
antifungal agent
antiperspirant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019531863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019526631A5 (enExample
Inventor
エフ． シャンバチャー、カール
エフ． シャンバチャー、カール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schanbacher carl f
Original Assignee
Schanbacher carl f
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schanbacher carl f filed Critical Schanbacher carl f
Publication of JP2019526631A publication Critical patent/JP2019526631A/ja
Publication of JP2019526631A5 publication Critical patent/JP2019526631A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87—Application Devices; Containers; Packaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
JP2019531863A 2016-08-29 2017-08-22 皮膚真菌感染症の処置のための方法及び組成物 Pending JP2019526631A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662380787P 2016-08-29 2016-08-29
US62/380,787 2016-08-29
PCT/US2017/047971 WO2018044621A1 (en) 2016-08-29 2017-08-22 Methods and compositions for treating cutaneous fungal infections

Publications (2)

Publication Number Publication Date
JP2019526631A true JP2019526631A (ja) 2019-09-19
JP2019526631A5 JP2019526631A5 (enExample) 2020-10-01

Family

ID=59799468

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019531863A Pending JP2019526631A (ja) 2016-08-29 2017-08-22 皮膚真菌感染症の処置のための方法及び組成物

Country Status (8)

Country Link
US (1) US10251822B2 (enExample)
EP (1) EP3503874A1 (enExample)
JP (1) JP2019526631A (enExample)
CN (1) CN109862882A (enExample)
AU (1) AU2017320876B2 (enExample)
CA (1) CA3034839A1 (enExample)
MX (1) MX382357B (enExample)
WO (1) WO2018044621A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102217617B1 (ko) * 2020-08-14 2021-02-19 비엘엔에이치 주식회사 백선의 예방 또는 치료용 약학적 조성물
WO2022149300A1 (ja) * 2021-01-08 2022-07-14 学校法人日本大学 白癬菌のスクアレンエポキシダーゼ阻害薬に対する耐性を判定する方法及び検査キット
JPWO2023042911A1 (enExample) * 2021-09-17 2023-03-23

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10993890B2 (en) * 2018-03-15 2021-05-04 Pelli Skin Co., Llc Antifungal solution and foot wipe
CN111450128A (zh) * 2020-06-01 2020-07-28 王刚建 一种用于治疗脚气的药物
US20230414537A1 (en) * 2022-06-21 2023-12-28 Taro Pharmaceutical Industries Ltd. Topical naftifine compositions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5824511A (ja) * 1981-07-17 1983-02-14 クラウス・リ−マン・アンド・カンパニ−・エイピ−エス 制汗用キツトとそのアプリケ−タ
JP2003335704A (ja) * 2002-05-17 2003-11-28 Xantech Pharmaceuticals Inc 制汗剤と抗菌剤の複合組成物
JP2004351632A (ja) * 2003-05-27 2004-12-16 Meisei Sansho Kk 薬液含浸シート
JP2007091643A (ja) * 2005-09-29 2007-04-12 Nippon Nohyaku Co Ltd 医療用抗白癬菌剤
WO2015051805A1 (en) * 2013-10-09 2015-04-16 Riemann Trading Aps Improved antiperspirant composition
JP2016027036A (ja) * 2014-06-30 2016-02-18 ロート製薬株式会社 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物
JP2016510034A (ja) * 2013-02-28 2016-04-04 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． 生体利用効率が向上したコルチコステロイドの局所製剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1024501A (en) * 1962-02-21 1966-03-30 Hardman & Holden Ltd Improvements relating to aerosol preparations
US4083954A (en) * 1975-04-04 1978-04-11 Kao Soap Co., Ltd. Aerosol composition
US4551330A (en) * 1983-06-30 1985-11-05 Helene Curtis Industries, Inc. Skin and hair conditioner compositions and conditioning method
DK483587D0 (da) 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
US5468473A (en) * 1994-02-09 1995-11-21 Innova Products, Inc. Antiperspirant for hands and feet
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
US20060003654A1 (en) * 2004-06-30 2006-01-05 Lostocco Michael R Dispersible alcohol/cleaning wipes via topical or wet-end application of acrylamide or vinylamide/amine polymers
KR20060009093A (ko) * 2004-07-20 2006-01-31 송재신 염산 테르비나핀을 함유하는 분말 에어로졸 조성물
KR101333892B1 (ko) * 2005-09-29 2013-11-27 노파르티스 아게 항진균 조성물
JP5453093B2 (ja) * 2007-09-05 2014-03-26 株式会社ポーラファルマ 抗真菌医薬組成物
US20100056430A1 (en) 2008-08-27 2010-03-04 Arnold Lester Treatment and Method for Eliminating or Reducing Foot Odor
JP2012516320A (ja) * 2009-01-30 2012-07-19 イッスム リサーチ デベロプメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム リミテッド 爪および皮膚を処置するための組成物
WO2010086727A1 (en) * 2009-01-30 2010-08-05 Galderma Pharma Sa Stable compositions for nail onychomycosis treatment
US20120061267A1 (en) 2010-09-14 2012-03-15 Sally Villalobos MediTowel Anti-Fungal Wipe
RU2567036C1 (ru) * 2014-10-28 2015-10-27 Государственное бюджетное учреждение Республики Башкортостан "Научно-исследовательский технологический институт гербицидов и регуляторов роста растений с опытно-экспериментальным производством Академии наук Республики Башкортостан" Средство ухода за кожей, обладающее антифунгальными свойствами (варианты)

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5824511A (ja) * 1981-07-17 1983-02-14 クラウス・リ−マン・アンド・カンパニ−・エイピ−エス 制汗用キツトとそのアプリケ−タ
JP2003335704A (ja) * 2002-05-17 2003-11-28 Xantech Pharmaceuticals Inc 制汗剤と抗菌剤の複合組成物
JP2004351632A (ja) * 2003-05-27 2004-12-16 Meisei Sansho Kk 薬液含浸シート
JP2007091643A (ja) * 2005-09-29 2007-04-12 Nippon Nohyaku Co Ltd 医療用抗白癬菌剤
JP2016510034A (ja) * 2013-02-28 2016-04-04 プレシジョン ダーマトロジー インコーポレイテッドＰｒｅｃｉｓｉｏｎ Ｄｅｒｍａｔｏｌｏｇｙ， Ｉｎｃ． 生体利用効率が向上したコルチコステロイドの局所製剤
WO2015051805A1 (en) * 2013-10-09 2015-04-16 Riemann Trading Aps Improved antiperspirant composition
JP2016027036A (ja) * 2014-06-30 2016-02-18 ロート製薬株式会社 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
財団法人 日本医薬情報センター 編集, 医療薬日本医薬品集, vol. 2000年版, JPN6022031384, 2000, pages 1227 - 1229, ISSN: 0005002592 *
高久史麿ら 監修, 治療薬マニュアル 2007, vol. 2007年版, JPN6022031385, 2007, pages 1655 - 1656, ISSN: 0005002593 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102217617B1 (ko) * 2020-08-14 2021-02-19 비엘엔에이치 주식회사 백선의 예방 또는 치료용 약학적 조성물
WO2022149300A1 (ja) * 2021-01-08 2022-07-14 学校法人日本大学 白癬菌のスクアレンエポキシダーゼ阻害薬に対する耐性を判定する方法及び検査キット
JPWO2023042911A1 (enExample) * 2021-09-17 2023-03-23
KR20240069718A (ko) 2021-09-17 2024-05-20 모찌다 세이야쿠 가부시끼가이샤 액취 방지용 조성물

Also Published As

Publication number Publication date
EP3503874A1 (en) 2019-07-03
CA3034839A1 (en) 2018-03-08
AU2017320876B2 (en) 2022-07-07
CN109862882A (zh) 2019-06-07
US20180055745A1 (en) 2018-03-01
MX382357B (es) 2025-03-13
WO2018044621A1 (en) 2018-03-08
US10251822B2 (en) 2019-04-09
MX2019002047A (es) 2019-10-04
AU2017320876A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
US10251822B2 (en) Methods and compositions for treating cutaneous fungal infections
KR100871401B1 (ko) 국소 글리코피롤레이트 제품
ES2436647T3 (es) Uso de quitosanos para aumentar la velocidad de crecimiento de las uñas
US12419959B2 (en) Dermal skin protectant and carrier
JP2005523240A (ja) 局所的な真菌性および細菌性の感染を治療する新規な方法
EP2691077A1 (en) Salicylic acid topical formulation
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
US20110236503A1 (en) Topical Skincare Composition
JP2017509705A (ja) 皮膚の疾患および障害の治療のための組成物
US20230293492A1 (en) Methods and compositions for treating cutaneous fungal infections
JP5643872B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2009001575A (ja) オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤
JP5164438B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP5699184B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
JP2007332078A (ja) オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤
JP2000212090A (ja) 皮膚改質剤
JP7257378B2 (ja) 水中油型エマルション
US20180104227A1 (en) Nail lacquer composition containing ciclopirox
JP5647809B2 (ja) 履物用抗真菌組成物
JP2016023183A (ja) 粉末状の痒み防止剤
JP5993336B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
WO2026060106A1 (en) Compositions and methods for treating cutaneous fungal infections
CA3118534C (en) Dermal skin protectant and carrier
US20240366658A1 (en) Deodorant compositions containing zinc and erythritol
WO2025264775A1 (en) Antimicrobial compositions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200821

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210914

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220802

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230301